Leaving Community
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Blog
dkNET community events and announcements in October, 2017
Dear dkNET Community,
dkNET provides updates on activities of interest to the NIDDK-supported community. You could keep up to date on these activities through our Twitter feed @dkNET_info, through our Community Calendar, or through dkNET e-mail list. If you have an event or funding opportunities you'd like to advertise, please contact us info_at_dknet.org.
Events in October, 2017
Oct. 3, 2017
T1D Exchange Annual Meeting
Location: Royal Sonesta Boston,
40 Edwin H Land Blvd, Cambridge, MA 02142, USA
More information: https://t1dexchange.org/pages/events/annual-meeting/
Oct. 4- Oct. 8, 2017
IDWeek (Infectious Diseases Annual Meeting)
Location: San Diego, CA, USA
More information: http://www.idweek.org
Oct. 5, 2017
Workshop Registration deadline: The Interface of Pancreatic Cancer Within Diabetes, Obesity and Inflammation: Research Gaps and Opportunities
The purpose of The Interface of Pancreatic Cancer with Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities Workshop is to explore the relationships of diabetes, obesity, and inflammation on the mechanisms, diagnosis and possible treatment of pancreatic ductal adenocarcinoma (PDAC). We plan sessions which will focus on the role of diabetes and altered intracellular metabolism on the development of PDAC, the mechanisms and diagnosis of PDAC-caused diabetes, the role of obesity as a risk factor and cause of PDAC, and the role of inflammation and immune mechanisms on the development and possible treatment of PDAC. Recommendations which arise from the workshop will inform possible future funding initiatives of NIDDK.
Location: Bethesda, MD, USA
Oct. 5, 2017
Scholarship and Discounted Abstract Deadline: Keystone Symposium: Frontiers in Islet Biology and Diabetes (B3)
More information: http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1568
Oct. 5 - Oct. 18, 2017
Advancing Disease
Modeling in Animal-Based Research in Support of Precision Medicine: A Workshop
An ad hoc planning committee will plan and conduct a public workshop to explore the potential of ongoing and future research in animal models with implications for precision medicine. This workshop will bring together experts on the use of state-of-the art technologies and technological advances to explore:
• How the
design, creation, and analysis of current and next-generation animal models can
inform the practice of precision medicine;
•
Reproducibility concepts to improve the clinical relevance of animal-based
validation experiments and pre-and co-clinical trials in the context of
precision medicine;
• Welfare and
regulatory considerations of current and especially next-generation animal
models that would inform the design of targeted, personalized therapies.
Location: Washington, DC, USA
More information: http://nas-sites.org/ilar-roundtable/roundtable-activities/precision-medicine-workshop/
Oct. 12, 2017
The Interface of
Pancreatic Cancer Within Diabetes, Obesity and Inflammation: Research Gaps and
Opportunities Workshop
The purpose of The
Interface of Pancreatic Cancer with Diabetes, Obesity, and Inflammation:
Research Gaps and Opportunities Workshop is to explore the relationships of
diabetes, obesity, and inflammation on the mechanisms, diagnosis and possible
treatment of pancreatic ductal adenocarcinoma (PDAC). We plan sessions which
will focus on the role of diabetes and altered intracellular metabolism on the
development of PDAC, the mechanisms and diagnosis of PDAC-caused diabetes, the
role of obesity as a risk factor and cause of PDAC, and the role of
inflammation and immune mechanisms on the development and possible treatment of
PDAC. Recommendations which arise from the workshop will inform possible future
funding initiatives of NIDDK.
Location: Bethesda, MD, USA
Oct. 12 - Oct. 13, 2017
Mayo Clinic
Metabolomics Symposium
Location: Rochester, MN, USA
More information: http://matrix.conferenceataclick.com/metabolomics_2017/home_live1.htm
Oct. 13, 2017
NIF Webinar: NIF And dkNET, Making Research Tools FAIR, presented by Dr. Jeffrey Grethe
The Neuroscience Information Framework (NIF; http://neuinfo.org) is an open community resource for researchers, educators, and students and trainees. NIF’s discovery portal facilitates access to a collection of diverse research resources (i.e. the multitude of data, software tools, materials, services, projects and organizations available to researchers in the public domain) that can help foster research through its Resource and Data Discovery Index. NIF utilizes many advanced features for information retrieval and integration. Chief among these is the use of a shared vocabulary for describing and querying resources which currently consists of thousands of concepts derived from community-built ontologies and vocabularies and enhanced through the input of neuroscience experts. NIF’s infrastructure is being used as a foundation for a number of initiatives that support the FAIR Principles. ensuring that data and information are Findable, Accessible, Interoperable, and Re-usable. This webinar will provide an introduction to the Neuroscience Information Framework, the tools and services available to the community, and an overview of initiatives being supported by NIF, and how one can contribute to and get involved with NIF.
More information: https://dknet.org/about/blog/1007
Oct. 13, 2017
2017 Mid-Atlantic Diabetes Research Symposium
The 2017 Annual Mid-Atlantic Diabetes Research Symposium is co-sponsored by the Diabetes, Endocrinology, and Obesity Branch (DEOB) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH); the Mid-Atlantic Nutrition Obesity Research Center (NORC) at the Department of Medicine, University of Maryland; the Johns Hopkins University-University of Maryland Diabetes Research Center (JHU-UMD-DRC); and the Foundation for Advanced Education in the Sciences (FAES) at the NIH. The purposes of this meeting are to encourage collaborations and enhance interactions at the regional level through the sharing of both reagents and expertise. Registration deadline: Oct. 12, 2017.
Location: Bethesda, MD, USA
More information: https://www.niddk.nih.gov/news/events-calendar/Pages/MidAtlanticDiabetes2017.aspx
Oct. 15, 2017
Registration deadline: Autoantigens Discovery and Characterization in Type 1 Diabetes
One of the goals of this workshop is to bring together investigators that use new methods and technologies to identify autoantigens and responses to them (antibodies or T-cells). Researchers with diverse expertise will share ideas and identify resources. This could help them uncover opportunities to work together to accelerate the progress of antigen/antigen response discovery and detection. The workshop also could bring in experts to advise on next steps and help discoveries transition to utility as biomarkers of disease progression, treatment response, and ultimately new antigen-specific therapeutics. Another goal of the workshop is to have a discussion on the progress and potential future development for (1) the identification of new autoantigens and epitopes in T1D; (2) the characterization of the response to new and previously known antigens (T-cell or humoral); and (3) the use of these antigens/epitopes and their response for identifying disease triggers and mechanisms, monitoring disease progression, and developing new treatments or preventative vaccines.
Location: North Bethesda, MDMore information: https://www.niddk.nih.gov/news/events-calendar/Pages/AutoAntigens2017.aspx
Oct. 15, 2017
Registration deadline: Workshop on Immune System Engineering for Targeted Tolerance in Type 1 Diabetes (T1D)
This workshop will explore research on deactivating immune responses specifically and safely in T1D and other disease contexts. The workshop will also explore the prospects for engineering immune regulation in the context of autoimmune attack through the direct manipulation of regulatory and other cells for applications in cell therapy. Intervention based on targeting mechanisms of tolerance has the potential for novel therapeutic agents to prevent or treat the disease, including both immunomodulatory materials and cellular therapy. In this workshop, scientists from diverse fields (bioengineering, microbiome research, cancer immunology, etc.) will come together with diabetes experts to discuss how new knowledge, tools and technologies may be applied to reverse autoimmunity.
Location: North Bethesda, MD
More information: https://www.niddk.nih.gov/news/events-calendar/Pages/TargetTolerance2017.aspx
Oct. 15 - Oct. 19, 2017
Keystone Symposium: Regenerative Biology and Applications: Cell Differentiation, Tissue Organization and Biomedical Engineering (T3)
Organized in collaboration with the Croucher Foundation and The University of Hong Kong; Held in honor of the 130th Anniversary of The University of Hong Kong Li Ka Shing Faculty of Medicine.
Location: Hong Kong
More information: http://www.keystonesymposia.org/17T3
Oct. 18 - Oct. 21, 2017
International Society for Pediatric and Adolescent Diabetes (ISPAD)
Location: Innsbruck, AustriaMore information: http://www.ispad.org/?page=ISPADConferences
Oct. 18, 2017
Registration deadline: ERCC9
Since 2013, the Extracellular RNA Communication Consortium has been working to understand the biological functions of extracellular RNAs and vesicles in the healthy body and in disease, to identify biomarkers of disease that can be assayed from biofluids rather than through an invasive biopsy, and to develop therapies for disease using extracellular RNA and extracellular vesicles.The ERCC is pleased to announce that our next semi-annual meeting will be held on November 6-7, 2017 at the Hilton Washington DC / Rockville Hotel & Executive Meeting Center, Rockville, Maryland. Come join us to share your work and hear about the latest developments in the field. The meeting is open to anyone who is interested, and there is no cost for registration.
Location: Washington, DC, USA
More information: http://exrna.org/ERCC9/
Oct. 22 - Oct. 26, 2017
15th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases (Bioactive Lipids 2017)
The Conference will be opened on 22 Oct and it will be end on 25 Oct 2017. The Eicosanoid Research Foundation calls you to Puerto Vallarta, for its 15th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases. It will be arranged at Marriott Casa Magna. 15th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases (Bioactive Lipids 2017) is going to be where Medical and Oncology pros unite to deliberate perceptions and point of views to advance insight for Medical, Health Care, Oncology, Cancer, Inflammation and Bioactive Lipids matters. 15th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases is organized biennially. The association of the 15th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases is Eicosanoid Research Foundation.
Location: Puerto Vallarta, Jalisco, MexicoMore information: https://bioactivelipidsconf.wayne.edu
Oct. 23, 2017
HIRN CHIB In-Person Investigator Meeting
HIRN Consortium on Human Islet Biomimetics (CHIB) In-Person Investigator: The meeting will take place The CHIB in-person Investigator Meeting will be held on Monday, October 23 – Tuesday, October 24, 2017 at the University of California, San Diego in California.
Location: La Jolla, CA
Oct. 24- Oct. 25, 2017
Enhancing Opportunities in Addressing Obesity and Type 2 Diabetes Disparities Workshop
The focus of this meeting is on socioecological approaches to preventing and treating obesity and type 2 diabetes with a specific focus on opportunities to address how socioecological context influences disease risks, as well as engagement in and response to interventions such as lifestyle changes and self-management. The overall workshop objectives are to: (1)identify aspects of the socioecological and health care delivery contexts that may be targeted to reduce obesity and diabetes disparities (2)assess the implications for interventions to reduce and/or eliminate disparities in obesity and diabetes that affect health disparities populations (3)identify important research opportunities to develop and test approaches to reduce or eliminate obesity and diabetes disparities.
Location: Bethesda, MD
More information: https://www.niddk.nih.gov/news/events-calendar/Pages/enhancing-opportunities-addressing-obesity-type-2-diabetes-disparities.aspx
Oct. 25, 2017
Scholarship and
Discount Abstract Deadline: Keystone Symposia - Uncomplicating Diabetes:
Reducing the Burden of Diabetes Related End-Organ Injury (J7)
Location: Santa Fe, NM
More information:http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1526
Oct. 26, 2017
Abstract Deadline: Keystone Meeting - Bioenergetics and Metabolic Disease (J4)
Obesity and type 2 diabetes are major drivers of chronic disease and premature death. A promising strategy to reduce obesity and improve metabolic health is through promoting energy expenditure via thermogenesis, including obligatory (accompanies all metabolic processes) and facultative (adaptive) mechanisms. Obesity and insulin resistance also lead to profound metabolic changes in various cells/tissues that contribute to tissue dysfunction. This conference brings together basic and clinical researchers from industry and academia focused on the study of cellular and organismal energy metabolism in the context of metabolic disease. A variety of approaches and topics will be featured, including: basic mechanisms of mitochondrial and cellular energetics; the emerging role of brown and beige fat in adaptive thermogenesis; central regulation of energy expenditure; and the effects of exercise on muscle and whole-body metabolism. In addition to the plenary sessions, the meeting will feature workshops on emerging research areas and novel therapeutic opportunities. Overall, the goals of the conference are to: 1) Provide a cutting-edge understanding of the basic mechanisms that control cellular and whole-body energetics; 2) Discuss the physiological role of brown fat and other energy expenditure pathways in humans; 3) Consider novel strategies for increasing energy expenditure and combating metabolic disease; and 4) Engage attendees in critical discussions about important areas for future research.
Location: Keystone, CO
More information: http://www.keystonesymposia.org/index.cfm?e=web.meeting.program&meetingid=1566
Oct. 26, 2017
Abstract deadline: Organ Crosstalk in Obesity and NAFLD
Since 2013, the Extracellular RNA Communication Consortium has been working to understand the biological functions of extracellular RNAs and vesicles in the healthy body and in disease, to identify biomarkers of disease that can be assayed from biofluids rather than through an invasive biopsy, and to develop therapies for disease using extracellular RNA and extracellular vesicles.The ERCC is pleased to announce that our next semi-annual meeting will be held on November 6-7, 2017 at the Hilton Washington DC / Rockville Hotel & Executive Meeting Center, Rockville, Maryland. Come join us to share your work and hear about the latest developments in the field. The meeting is open to anyone who is interested, and there is no cost for registration. Neural and humoral communication among peripheral organs and the brain is critical in coordinating whole body energy homeostasis in health and disease. Nutrient and hormone sensing take place in multiple organs with the central nervous system as a site of integration of these diverse signals, governing this coordination. Within this multi-organ framework, the liver occupies a central role in determining systemic glucose and lipid metabolism in obesity and clinically relevant metabolic pathophysiology, particularly non-alcoholic fatty liver disease (NAFLD) and fibrosis. Identification and characterization of the modes and consequences of organ cross-talk is essential to fill existing gaps in knowledge and to promote the development of therapeutic strategies to treat obesity and metabolic disease. This conference brings together experts in the novel, multidisciplinary evaluation of organ cross-talk, using innovative combinations of molecular, genetic, physiological, pharmacological and systems neuroscience approaches to: 1) Provide a unique and timely perspective, and 2) Inspire interactions directed toward basic, clinical and translational research in integrative metabolism. Finally, the joint staging of this conference in conjunction with the conference on “Bioenergetics and Metabolic Disease” will strategically leverage presentations targeting the biology of metabolism and nutrient availability in obesity with those focused on the biology of energy utilization. Taken together, this novel combination will provide a coherent, powerful and comprehensive understanding of and appreciation for the complex.
Location: Keystone, CO
More information: http://www.keystonesymposia.org/index.cfm?e=web.meeting.summary&meetingid=1565&subtab=summary
Oct. 26, 2017
Abstract Deadline: Keystone Meeting - Bioenergetics and Metabolic Disease (J4)
Obesity and type 2 diabetes are major drivers of chronic disease and premature death. A promising strategy to reduce obesity and improve metabolic health is through promoting energy expenditure via thermogenesis, including obligatory (accompanies all metabolic processes) and facultative (adaptive) mechanisms. Obesity and insulin resistance also lead to profound metabolic changes in various cells/tissues that contribute to tissue dysfunction. This conference brings together basic and clinical researchers from industry and academia focused on the study of cellular and organismal energy metabolism in the context of metabolic disease. A variety of approaches and topics will be featured, including: basic mechanisms of mitochondrial and cellular energetics; the emerging role of brown and beige fat in adaptive thermogenesis; central regulation of energy expenditure; and the effects of exercise on muscle and whole-body metabolism. In addition to the plenary sessions, the meeting will feature workshops on emerging research areas and novel therapeutic opportunities. Overall, the goals of the conference are to: 1) Provide a cutting-edge understanding of the basic mechanisms that control cellular and whole-body energetics; 2) Discuss the physiological role of brown fat and other energy expenditure pathways in humans; 3) Consider novel strategies for increasing energy expenditure and combating metabolic disease; and 4) Engage attendees in critical discussions about important areas for future research.
Location: Keystone, CO
More information: http://www.keystonesymposia.org/index.cfm?e=web.meeting.program&meetingid=1566
Oct. 26 - Oct. 27, 2017
2017 Sex as a Biological Variable Workshop
In 2015, the National Institutes of Health (NIH) announced policy changes to ensure that sex as a biological variable is considered in vertebrate animals and human studies. The 2017 Sex as a Biological Variable (SABV) Workshop will take place October 26-27, 2017, at the NIH campus in Bethesda, MD. This one and one-half day long workshop is intended to address the advantages of incorporating SABV in biomedical research.
The workshop will highlight the scientific insights of a select number of supplement recipients who received funding through the NIH Office of Strategic Coordination and the Office of Research on Women's Health to address sex differences in brain function and behavior, sex effects/interactions with external influences, sex differences in animal models, and sex differences in gene expression. Researchers will present their scientific results and share on challenges and approaches to inclusion of SABV in research design spanning the entire continuum from basic through translational to clinical research analyses and reporting. It will also include a panel discussion on accounting for SABV in biomedical research. This workshop will inform the development of a white paper for the broader scientific community on analytic strategies for incorporating SABV into biomedical research.
Location: Bethesda, MD
More information: https://ww2.eventrebels.com/er/EventHomePage/CustomPage.jsp?ActivityID=21607&ItemID=77707
Oct. 30 - Nov. 3, 2017
10th Annual Course on Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis
The tenth annual course provides basic introductory and comprehensive information on performing metabolic studies using tracers labeled with radioactive or stable isotopes, in humans and in animals. The course is designed for beginners as well as those with experience who wish to expand their capabilities to more sophisticated problems. The faculty is well-versed in a variety of applications and methodologies. Techniques will be presented for investigating whole body metabolism, for metabolite balance across organs, intracellular flux rates and pathway regulation. The basic aspects of modeling will be considered, as well as specific applications to the study of carbohydrate, fat, protein metabolism and energy balance. Theoretical and practical matters related to sample analysis by mass spectrometry and NMR will be discussed, including detailed numerical examples of calculations involved in determining isotopic enrichment and basic kinetic parameters. Advanced lectures will discuss in more detail the use of positional and mass isotopomer analysis for intracellular flux rates and various aspects of protein and amino acid metabolism.
Location: Nashville, TN, USA
More information: https://www.niddk.nih.gov/news/events-calendar/Pages/10th-annual-course-isotope-tracers-metabolic-research.aspx
Oct. 31 - Nov. 2, 2017
Obesity Week 2017- American Society for Metabolic & Bariatric Surgery and The Obesity Society Joint Annual Meeting
The Obesity Society’s
Annual Scientific Meeting has grown to be one of the world’s largest gatherings
of obesity professionals at all stages of their careers, including leading
obesity scientists presenting cutting-edge research. The meeting brings
together the leading players in the field of obesity from world-renowned
speakers, researchers and clinicians to educators, advocates, policymakers and
practitioners. And, it provides essential educational and networking
opportunities and is a forum for increasing knowledge, stimulating research,
and promoting better treatment for those affected by this disease.
Location: Washington DC
More information: http://www.obesity.org/meetings/obesity-week
Oct. 31 - Nov. 1, 2017
Autoantigens Discovery and Characterization in Type 1 Diabetes Workshop
One of the goals of
this workshop is to bring together investigators that use new methods and
technologies to identify autoantigens and responses to them (antibodies or
T-cells). Researchers with diverse expertise will share ideas and identify
resources. This could help them uncover opportunities to work together to
accelerate the progress of antigen/antigen response discovery and detection.
The workshop also could bring in experts to advise on next steps and help
discoveries transition to utility as biomarkers of disease progression,
treatment response, and ultimately new antigen-specific therapeutics. Another
goal of the workshop is to have a discussion on the progress and potential
future development for (1) the identification of new autoantigens and epitopes
in T1D; (2) the characterization of the response to new and previously known
antigens (T-cell or humoral); and (3) the use of these antigens/epitopes and
their response for identifying disease triggers and mechanisms, monitoring
disease progression, and developing new treatments or preventative vaccines.
More information: https://www.niddk.nih.gov/news/events-calendar/Pages/AutoAntigens2017.aspx
Funding opportunities information and deadlines in October, 2017
Oct. 1, 2017
Letter of Intent Due Date: George M. O'Brien Kidney Research Core
Centers (P30)
This Funding
Opportunity Announcement (FOA) invites applications for the George M. OBrien
Kidney Research Centers to support both basic and clinical research on kidney
disease. The goal of the O'Brien Kidney Research Center program is to make
state-of-the art technologies and resources readily accessible to a broad
spectrum of investigators pursuing studies in relevant topic areas. The
emphases for this program are fourfold: (1) to attract new scientific expertise
to and develop new tools for the study of human kidney physiology and disorders
in humans and in animal and other models; (2) to encourage multidisciplinary
research in these areas; 3) To explore new areas with translational potential;
and 4) to generate Developmental Research (DR)/Pilot and Feasibility (P and F)
studies which could lead to new and innovative approaches to study kidney
disease.
More information: https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-dk-17-005
Oct. 2, 2017
Letter of Intent Due Date: Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54)
This Funding Opportunity Announcement (FOA) invites applications for a Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54). The purpose of this Center is to: foster the study of individuals with rare/atypical forms of diabetes mellitus; identify and analyze phenotypic and genotypic defects that may provide insights into more common, heterogeneous forms of Type 2 diabetes mellitus (T2DM) in the general population; and develop a community resource to advance research in this area through the collection and dissemination of data and samples for access by the broad research community. To achieve this goal, the Center should support the following primary research endeavors: (1) develop a process for identifying and studying individuals/families with rare and uncharacterized forms of diabetes and (2) create and manage a database and biospecimen repository of rare/atypical forms of diabetes for use by the broader research community in future analyses.
More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-006.html
Oct. 2, 2017
Letter of intent due
date: Columbia University Medical Center Diabetes Research Center Pilot
Feasibility Grants
The Columbia Diabetes Research Center (DRC) announces the availability of Pilot and Feasibility grants to support diabetes-related research at Columbia University.
More information: https://www.derc.cumc.columbia.edu/pilot-feasibility-grant
Oct. 2, 2017
Funding Opportunities Application Due Date: UCLA Children's Discovery And Innovation Institute Seed Grant
The UCLA Children's Discovery and Innovation Institute (CDI) Seed Grants provides awards of up to $30,000 for one year for junior faculty conducting child health research to generate preliminary data needed for subsequent applications to federal and private funding agencies. Eligible faculty for Principal Investigator must hold a primary or secondary appointment in the Department of Pediatrics at the level of Clinical Instructor, Assistant Professor, or Associate Professor. At least one Co-Investigator must be a faculty member whose primary appointment is outside the Department of Pediatrics. Substantive collaboration with multiple UCLA schools and departments is emphasized for this award. The CDI, established in 2013 at the David Geffen School of Medicine at UCLA, encourages innovative and multidisciplinary child health research and research training at UCLA across the spectrum of basic, translational, clinical, and health services research. Eligible faculty for Principal Investigator must hold a primary or secondary appointment in the Department of Pediatrics at the level of Clinical Instructor, Assistant Professor, or Associate Professor.More information: https://www.uclahealth.org/Mattel/Pages/research-and-education/ucla-childrens-discovery-and-innovation-institute/cdi-research-grant-funding/cdi-seed-grants.aspx
Oct. 4, 2017
Letter of Intent Due Date: Boston Nutrition Obesity Research Center Pilot And Feasibility Program
The mission of the NIDDK-funded Boston Nutrition Obesity Research Center (BNORC) is to facilitate and support the conduct of cutting edge basic and translational research in the fields of nutrition and obesity science in the Boston area. BNORC’s Pilot and Feasibility Program provides funding on a competitive basis for new investigators who are transitioning to an independent line of research or established investigators with novel ideas in the area of nutrition and obesity research. Applications that address the themes of the Center will be given higher priority. These themes are: Nutrient Metabolism in Health and Disease, Brain Control of Feeding Behavior and Metabolism, Environmental and Genetic Influences on Obesity and Related Chronic Diseases.
More information: http://www.bumc.bu.edu/bnorc/pilot-and-feasibility-program/
Oct. 6, 2017
Funding Opportunity Letter of Intent Deadline: Melanoma Research Alliance (MRA): Team Science Awards
Awards for team science are designed to foster a collaborative research process and promote transformational melanoma research advances with the potential for rapid clinical translation. Multidisciplinary teams of two or more established Principal Investigators and a Young Investigator with complementary expertise will receive up to $900,000 total over 3 years, to support projects with the potential to lead to transformative advances in prevention, detection, diagnosis, staging and/or treatment of melanoma.Letters of Intent (LOIs) are due on October 6, 2017. Invited full length proposals from meritorious LOIs are due on January 9, 2018. Eligibility: Teams may consist of investigators from the same institution, different institutions, and may be international.
More information: http://www.curemelanoma.org/research/request-for-proposals/
Oct. 9, 2017
Funding Opportunity Application deadline: Center For Interdisciplinary Research On AIDS (CIRA) At Yale University Pilot Project
The Center for Interdisciplinary Research on AIDS (CIRA) at Yale University seeks letters of intent for its annual Pilot Projects in HIV/AIDS Prevention Research program. The goal of the program is to provide pilot funding that will result in additional externally funded research projects. We will consider letters of intent for applications for short-term funding support for preliminary, formative, or feasibility studies that will inform the development of larger, peer-reviewed research that can compete successfully for NIH or other funding. Applicants may propose to collect new data or to analyze data from completed R01, R03, R21 grants, other externally-funded projects, or previous CIRA pilot projects for the purpose of developing a new research agenda and funding. Eligibility: The program is open to full-time faculty and postdoctoral fellows and associates at Yale University, The Institute for Community Research (ICR), and the Center for Health, Intervention, and Prevention (CHIP) at UConn. Investigators from other universities or colleges and community-based organizations are eligible to apply in collaboration with a Principal Investigator based at Yale, ICR, or CHIP. It is our expectation that awardees will hold an appointment at one of these institutions for at least one year past the award date.
More information: http://cira.yale.edu/opportunities/pilot-projects-hivaids-prevention-research
Oct. 9, 2017
Funding Opportunity Application Deadline: Pennington Biomedical Research Center, Nutrition Obesity Research Center Pilot and Feasibility Grant
The major objective of this program is to provide research support to test innovative hypotheses from individuals or multidisciplinary teams involving nutrition/obesity-related research and other pilot studies related to the function of the NORC. Applicants should note that the theme of the PBRC NUTRITION OBESITY RESEARCH CENTER is “Nutrition, Obesity and Metabolic Health throughout the Lifespan.” In accord with our NORC award from NIDDK-NIH, we will be developing collaborative research teams focusing on three critical periods of the life cycle: Maternal/Infant nutritional status and metabolic consequences; Pediatric and adulthood obesity and metabolic health; Nutritional status at older age to preserve physical and cognitive functionality.
More information: http://norc.pbrc.edu/pfgrants.aspOct. 13, 2017
Application deadline: Joslin Diabetes Center Pilot And Feasibility Studies
As part of the NIH grant that supports Joslin Diabetes Center’s Diabetes and Research Center (DRC), the Pilot & Feasibility (P&F) Program offers funding each year for two studies in the areas of type 1 diabetes, type 2 diabetes or their complications. The P&F awards may be from basic, translational or clinical perspectives. The goal of the P&F Program is to encourage research on diabetes and its complications by two target groups: young diabetes researchers who recently became independent and have not yet received significant NIH or other funding, and seasoned investigators either entering the diabetes field for the first time or exploring a completely new direction. Letter of Intent: September 15, 2017.
More information: https://joslinresearch.org/p-f-studiesOct. 13, 2017
Funding Opportunity Application Deadline: The Wisconsin Alzheimer’s Disease Research Center (ADRC) Pilot and Feasibility Grant
The Wisconsin Alzheimer’s Disease Research Center (ADRC) announces the availability of funds to support pilot/feasibility studies targeting research in Alzheimer’s disease (AD) and related disorders. The major objective of this program is to enhance novel AD-related research throughout the University of Wisconsin campus, and generate pilot data for larger peer-reviewed grants. Geriatric-focused applications are encouraged.
More information: http://www.adrc.wisc.edu/pilot-funding-available
Oct. 16, 2017
Funding Opportunity Application Deadline: Pennington Biomedical Research Center Nutrition Obesity Research Center Pilot And Feasibility Grant 2017 Special RFA On "Nutrition, Obesity, And Cancer"
Approximately $60,000 is available to fund one or two P&F grants around the theme of nutrition, obesity and cancer. The major objective of this program is to provide research support to develop preliminary data and/or potential novel approaches (methods) from pairs of investigators with one investigator from LSU-HSC in New Orleans (cancer expertise) and the other from Pennington Biomedical (obesity expertise). The hope for a Pilot and Feasibility Award is that it will generate enough preliminary data for the investigator(s) to obtain research funding by conventional mechanisms (e.g., R01). This program needs to have at least one of the 2 investigators (either from LSU-HSC or from PBRC) to be a young investigator while the other can be more a mentor in the execution of the scientific proposal.
More information: https://norcfunding.pbrc.edu/members/researchfunding/View.aspx?key=184ecfbe-28a4-48ae-8acf-dda4faa7ed0e
Oct. 20, 2017
Funding Opportunity Application Due Date: National Metabolomics Data Repository (NMDR) (U2C)
This Funding Opportunity Announcement (FOA) addresses the need for a robust National Metabolomics Data Repository to store, and make publicly available, raw and processed metabolomic data generated by large NIH programs, individual research grants, and other biomedical research groups. Data, associated metadata, and the essential tools critical for accessing the key information will be housed in a cloud computing environment accessible for searching and reanalysis by the biomedical research community. The Metabolomics Data Repository and Coordination Center (DRCC), created in Stage I of the Common Fund Metabolomics Program, has begun to address this need. In the transition to a National Metabolomics Data Repository, the successful applicant is expected to continue and enhance the current technical capabilities of the Data Repository and create a governance structure that engages the wider metabolomics community to guide the repository’s efforts toward continual technical improvement and expansion and policy development for data deposition, access, and citation.More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-17-011.html
Oct. 20, 2017
Funding Opportunity Application Due Date: Metabolomic Data Analysis and Interpretation Tools (U01)
The goal of this cooperative agreement Funding Opportunity Announcement (FOA) is to address key challenges in analyzing and interpreting metabolomics data by developing novel tools to facilitate metabolomics data analysis and interpretation. Specifically, successful awardees will develop new or enhanced computational approaches or tools that facilitate metabolomics data analysis, interpretation, and integration. Generalizable, scalable, and portable solutions appropriate for scientists with limited expertise in informatics are particularly encouraged. Projects are not intended to supplement ongoing metabolomics analyses, but to provide tools for broader use by the biomedical research community.
More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-17-012.html
Oct. 20, 2017
Funding Opportunities Application Due Date: Stakeholder Engagement and Program Coordination Center (SEPCC) (U2C)
This Funding Opportunity Announcement (FOA) solicits applications to establish a Stakeholder Engagement and Program Coordination Center (SEPCC) to coordinate the required activities of the Common Fund Metabolomics Program Consortium; to engage the stakeholder community in identifying and developing strategies to address outstanding concerns in the application of metabolomics to biomedical research; and to promote use of Consortium resources by the greater biomedical research community. The Common Fund Metabolomics Program views community engagement and multi-directional communication as essential to overcome challenges in realizing the potential of metabolomics in biomedical research.
More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-17-014.htmlOct. 20, 2017
Funding Opportunities Application Due Date: Compound Identification Development Cores (U2C)
This Funding Opportunity Announcement (FOA) invites applications to establish Compound Identification Development Cores (CIDC) to develop innovative approaches to enhance compound identification of the most significant, biomedically-relevant unknown metabolites. The ultimate goal of this FOA is to expand the repertoire of biologically relevant compounds that can be quickly and inexpensively identified in high throughput metabolomics experiments. An interdisciplinary approach and partnership among metabolomics experts, biomedical researchers, chemists, and computational experts will be integral to the success of this goal, and advances made through this initiative are expected to be catalytic to the field.
More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-17-013.html
Oct. 24, 2017
Funding Opportunity Application Due Date: Pragmatic Research in Healthcare Settings to Improve Kidney Disease Prevention and Care (R18)
The purpose of this Research Demonstration and Dissemination Projects (R18) Funding Opportunity Announcement (FOA) is to encourage research applications to test approaches to improve kidney disease prevention and/or treatment in routine healthcare settings. Research applications should be designed to test practical and potentially sustainable strategies that target the prevention or improved care of kidney disease, or the prevention or delay of the complications of kidney disease. The goal of the research is to obtain results that will improve routine healthcare practice and inform healthcare policy for the prevention or management of these conditions.
More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-008.html
Oct. 27, 2017
Funding Opportunity Application Due Date: UNC Nutrition Obesity Research Center Pilot & Feasibility Grant Program
The primary objective
of the Pilot & Feasibility Grant Program is to support the development of
innovative research in nutrition and obesity. The program is specifically
designed to help investigators collect preliminary data sufficient enough to
support a grant application for independent research support and published
work. Project Criteria: Pilot & Feasibility projects may be biomedical,
epidemiological, clinical or translational. They may include laboratory or
non-laboratory research projects that focus either on human nutrition or on
animal work that could be translated to human nutrition. Human nutrition
projects may focus on inpatient or outpatient studies or on
epidemiological/community-based research that is social or behavioral in
nature. Applicant Eligibility: The applicants must be a faculty member at
UNC-CH who is a (1) new investigator without current or past NIH research
support (R01, P01, or R24) as a PD/PI, or (2) an established, funded
investigator with no previous work experience in nutritional sciences, and/or
obesity who wishes to test the applicability of their expertise to a
nutritional science and/or obesity-related problem. Funding: The NORC funds
1-year grants up to $20,000. The actual amount of the award and number of
awards made will depend upon the quality of the proposals received and the
availability of funding. Expenditures may begin at any time after the project’s
start date (April 1st); however, the entire award should be expended within one
year of receipt. Renewal for a second year of funding is possible for
meritorious projects that have made appropriate progress during the first year.
P&F funding is not intended for the extension of projects for which it
would be appropriate to submit a research project grant application. Funds are
also not intended to support or supplement ongoing research projects.
Oct. 27, 2017
Letter of Intent Due Date: The Texas Medical Center Digestive Diseases Center Pilot Feasibility Program
The Texas Medical Center Digestive Diseases Center (DDC) announces the availability of grant funds to support pilot/feasibility (P/F) projects in the area of GI-related research. These funds will support projects related to the theme for the DDC - GI infection and injury. GI is defined as the gastrointestinal tract, liver and pancreas. Injury is defined as drug, genetic, ischemic, inflammatory, surgical, nutritional, or stress-induced injury to the gastrointestinal tract. Injury also includes gastrointestinal adaptation and stem cells. Projects should relate to this theme. Awards will be for ~ $15,000 to $35,000 for a period of one year (earliest start date is March 1, 2017). A committee composed of the DDC Internal Advisory Board, plus ad hoc members, will evaluate proposals. The purpose of these grants is to help young investigators establish an independent research program and to encourage the involvement of established investigators not currently working in the GI area. It is highly recommended that members of the DDC Advisory Committee (listed above) be consulted during the preparation of applications. All faculty members from the Texas Medical Center are eligible. Faculty members at other institutions are eligible if they submit a grant that collaborates with a faculty member at the Texas Medical Center who is also a member of the Digestive Diseases Center. Trainees who are recipients of an NRSA individual award (F32) or are supported by an institutional training grant (T32) are eligible for P/F funds, if they are in their last year of training, have had at least one year of research laboratory experience, and have suitable expertise and independence to design and carry out the planned experiments. Trainees should have a commitment from a senior scientist to sponsor their projects. US citizenship or permanent resident status is not required. Funding preference will be given to junior faculty.More information: https://www.bcm.edu/research/centers/digestive-disease/funding
Oct. 30, 2017
Funding Opportunity
Application Deadline: University Of Alabama At Birmingham Diabetes Research
Center
The pilot and
feasibility program is intended to provide seed support for new and innovative
research projects directed at basic, biochemical, translational, clinical, and
community-based research questions that broadly pertain to diabetes, diabetes
complications, and cardiometabolic disease. Pilot projects should be designed
to generate sufficient data as the basis for further extramural funding (e.g.,
R01 applications) in order to substantially pursue and expand the line of
investigation. In fact, in order to
respond to NIH criteria for competitive renewal of the DRC, a key priority for
your application should be to focus on subsequent extramural or R01 grant
funding. Thus, your application will be
reviewed with this in mind so please provide a short paragraph indicating how
the award will facilitate R01 application development and the submission of a
proposal. We will entertain 2 year
projects if justification for the need is made in order to effectively develop
an R01 (you will have to reapply in November of 2016 to get funded for your
second year).Eligibility: Funding will
be available to full time UAB faculty members who must meet one of the criteria
listed below. Please note that
applications from post-doctoral fellows will be considered if there is a clear
plan and written documentation for transition to a faculty position at UAB
before the initiation date of the pilot grant award. Post-doctoral applicants will be asked to
identify a faculty member who will provide research advice, but the work should
support independent research and career development for the fellow/junior faculty
member.1. Junior investigators (e.g., Associate Professors or below who have
not been PI on a previous NIH R01 grant).2. Established investigators with no
previous work in diabetes who wish to apply their expertise to a problem in
this area.3. Established investigators in diabetes who want to pursue high
impact/high risk projects to test truly innovative ideas that represent a clear
departure from ongoing research interests.4. Note: We will also consider multidisciplinary
projects that involve both basic and clinical scientists who combine efforts in
‘translational’ research protocols, which could not be conducted by basic or
clinical scientist(s) alone. Eligibility: UAB Faculty members who meet one of
the criteria listed, post-doctoral fellows will be considered if there is a
clear plan and written documentation for transition to a faculty position at
UAB before the initiation date of the pilot grant award.
More information: https://www.uab.edu/shp/drc/award-programs/pilot-and-feasibility-program
Oct. 31, 2017
JDRF Funding Opportunity Application Deadline: Prevention Innovative Awards
JDRF provides seed funding for highly innovative research with significant potential to accelerate the mission of JDRF. JDRF requests proposals for prevention of type 1 diabetes with the therapeutic goals on prevention or delay of onset of beta cell-specific autoimmunity (Stage 1) or clinical T1D (Stage 3) in individuals at-risk of developing T1D.
More information: https://dknet.org/about/dknetnews/990Oct. 31, 2017
JDRF Funding Opportunity Application Deadline: Beta Cell Replacement Innovative Awards
JDRF provides seed
funding for highly innovative research with significant potential to accelerate
the mission of JDRF. Proposals should address key outstanding questions and
have the potential to lead to a change in the current paradigm or conventional
wisdom and/or lead to a groundbreaking discovery. JDRF requests proposal for
beta cell replacement innovative awards. In this awards, JDRF looks for a beta cell
replacement product capable of delivering insulin independence for at least 1
year with no chronic immunosuppression therapy.
More information: https://dknet.org/about/dknetnews/989
Oct. 31, 2017
Funding Opportunity
Application Deadline: Boston Area Diabetes Endocrinology Research Center Pilot
Grants
The Boston Area
Diabetes Endocrinology Research Center is funded by the National Institute of
Diabetes and Digestive Diseases (NIDDK) to support research in Diabetes and its
complications.
More information: http://www.baderc.org/feasibility/PFgrantsCore.html
About
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant 2U24DK097771-09.
Recent News Entries
Contact Us
Email: info_at_ dknet.org
